148 related articles for article (PubMed ID: 34997917)
1. Systematic Data Monitoring and Analysis of Cardiovascular Off-label Prescriptions in Pediatrics: Focus on Angiotensin-Converting Enzyme Inhibitors (ACE-I) and Beta Blockers.
Cammarata SM; Capone G; Lombardi N; Pani L; Mugelli A
High Blood Press Cardiovasc Prev; 2022 Mar; 29(2):169-195. PubMed ID: 34997917
[TBL] [Abstract][Full Text] [Related]
2. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
Pratico AD; Longo L; Mansueto S; Gozzo L; Barberi I; Tiralongo V; Salvo V; Falsaperla R; Vitaliti G; La Rosa M; Leonardi S; Rotondo A; Avola N; Sgarlata D; Damiano A; Tirantello M; Anzelmo G; Cipolla D; Rizzo A; Russo A; Ruggieri M; Salomone S; Drago F
Curr Drug Saf; 2018; 13(3):200-207. PubMed ID: 29921210
[TBL] [Abstract][Full Text] [Related]
3. Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches.
Carnovale C; Conti V; Perrone V; Antoniazzi S; Pozzi M; Merlino L; Venegoni M; Clementi E; Radice S
Eur J Pediatr; 2013 Dec; 172(12):1679-85. PubMed ID: 23913312
[TBL] [Abstract][Full Text] [Related]
4. Paediatric drug use with focus on off-label prescriptions in Swedish outpatient care--a nationwide study.
Olsson J; Kimland E; Pettersson S; Odlind V
Acta Paediatr; 2011 Sep; 100(9):1272-5. PubMed ID: 21438922
[TBL] [Abstract][Full Text] [Related]
5. Drug utilization and off-label drug use among Spanish emergency room paediatric patients.
Morales-Carpi C; Estañ L; Rubio E; Lurbe E; Morales-Olivas FJ
Eur J Clin Pharmacol; 2010 Mar; 66(3):315-20. PubMed ID: 19936729
[TBL] [Abstract][Full Text] [Related]
6. Incidence of unlicensed and off-label prescription in children.
Langerová P; Vrtal J; Urbánek K
Ital J Pediatr; 2014 Feb; 40():12. PubMed ID: 24495454
[TBL] [Abstract][Full Text] [Related]
7. Prescription Pattern Monitoring and Off-label Use of Medicines in the Pediatric Department at Tertiary Care Teaching Hospital.
Pandey S; Yadav CK; Ghimire P; Shrestha AC
Kathmandu Univ Med J (KUMJ); 2020 Oct.-Dec.; 18(72):367-371. PubMed ID: 34165093
[TBL] [Abstract][Full Text] [Related]
8. Regulating pediatric off-label uses of medicines in the EU and USA: challenges and potential solutions : Comparative regulation framework of off label prescriptions in pediatrics: a review.
Guidi B; Parziale A; Nocco L; Maiese A; La Russa R; Di Paolo M; Turillazzi E
Int J Clin Pharm; 2022 Feb; 44(1):264-269. PubMed ID: 34495453
[TBL] [Abstract][Full Text] [Related]
9. Off-label drug use among hospitalised children: identifying areas with the highest need for research.
Hsien L; Breddemann A; Frobel AK; Heusch A; Schmidt KG; Läer S
Pharm World Sci; 2008 Oct; 30(5):497-502. PubMed ID: 18219585
[TBL] [Abstract][Full Text] [Related]
10. Comparative Assessment of Off-label and Unlicensed Drug Prescriptions in Children: FDA Versus ANSM Guidelines.
Berdkan S; Rabbaa L; Hajj A; Eid B; Jabbour H; Osta NE; Karam L; Khabbaz LR
Clin Ther; 2016 Aug; 38(8):1833-44. PubMed ID: 27392716
[TBL] [Abstract][Full Text] [Related]
11. Trends in the off-label use of β-blockers in pediatric patients.
Kaley VR; Aregullin EO; Samuel BP; Vettukattil JJ
Pediatr Int; 2019 Nov; 61(11):1071-1080. PubMed ID: 31571355
[TBL] [Abstract][Full Text] [Related]
12. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
[TBL] [Abstract][Full Text] [Related]
13. Off-label drug use in pediatric patients: a comparative analysis with nationwide routine prescription data.
Akıcı N; Kırmızı Nİ; Aydın V; Bayar B; Aksoy M; Akıcı A
Turk J Pediatr; 2020; 62(6):949-961. PubMed ID: 33372433
[TBL] [Abstract][Full Text] [Related]
14. [Off-label pediatric medicines in Spain].
Piñeiro Pérez R; Núñez Cuadros E; Rodríguez Marrodán B; Escrig Fernández R; Gil Lemus MÁ; Manzano Blanco S; Calvo C
An Pediatr (Engl Ed); 2021 Mar; 94(3):188.e1-188.e9. PubMed ID: 33509731
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of unlicensed and off-label antiepileptic drugs prescribed to children: Brazilian Regulatory Agency versus FDA.
Borges AP; Campos MS; Pereira LR
Int J Clin Pharm; 2013 Jun; 35(3):425-31. PubMed ID: 23430533
[TBL] [Abstract][Full Text] [Related]
16. Drug utilization and off-label drug use in Spanish pediatric gastroenterology outpatients.
Ruíz-Antorán B; Piñeiro R; Avendaño C; Román E; Cilleruelo ML; Gutiérrez-Junquera C; Centeno G; Cilleruelo MJ
J Pediatr Gastroenterol Nutr; 2013 Feb; 56(2):173-7. PubMed ID: 23328455
[TBL] [Abstract][Full Text] [Related]
17. Off-label use of medicine in pediatrics: focus on gastrointestinal diseases.
Karesh A; Tomaino J; Mulberg AE
Curr Opin Pediatr; 2013 Oct; 25(5):612-7. PubMed ID: 23995427
[TBL] [Abstract][Full Text] [Related]
18. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
[TBL] [Abstract][Full Text] [Related]
19. Frequency of the off-label use of antibiotics in clinical practice: a systematic review.
Tansarli GS; Rafailidis PI; Kapaskelis A; Falagas ME
Expert Rev Anti Infect Ther; 2012 Dec; 10(12):1383-92. PubMed ID: 23253317
[TBL] [Abstract][Full Text] [Related]
20. Change in prescription pattern as a potential marker for adverse drug reactions of angiotensin converting enzyme inhibitors.
Mahmoudpour SH; Asselbergs FW; de Keyser CE; Souverein PC; Hofman A; Stricker BH; de Boer A; Maitland-van der Zee AH
Int J Clin Pharm; 2015 Dec; 37(6):1095-103. PubMed ID: 26159317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
